Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Interest & Investment Income: 2021-2024

Historic Interest & Investment Income for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Dec 2024 value amounting to $13.8 million.

  • Amylyx Pharmaceuticals' Interest & Investment Income fell 41.22% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 47.50%. This contributed to the annual value of $13.8 million for FY2024, which is 14.52% down from last year.
  • Amylyx Pharmaceuticals' Interest & Investment Income amounted to $13.8 million in FY2024, which was down 14.52% from $16.2 million recorded in FY2023.
  • In the past 5 years, Amylyx Pharmaceuticals' Interest & Investment Income registered a high of $16.2 million during FY2023, and its lowest value of $36,000 during FY2021.
  • For the 3-year period, Amylyx Pharmaceuticals' Interest & Investment Income averaged around $11.4 million, with its median value being $13.8 million (2024).
  • As far as peak fluctuations go, Amylyx Pharmaceuticals' Interest & Investment Income soared by 11,819.44% in 2022, and later declined by 14.52% in 2024.
  • Yearly analysis of 4 years shows Amylyx Pharmaceuticals' Interest & Investment Income stood at $36,000 in 2021, then soared by 11,819.44% to $4.3 million in 2022, then surged by 276.49% to $16.2 million in 2023, then decreased by 14.52% to $13.8 million in 2024.